News

Here are some of the things we are doing at the moment

Latest news

July 25th 2017 - Optibrium and Bugworks Sign Agreement for StarDrop License
Antimicrobial resistance Biopharma selects StarDrop to guide discovery of next generation of antibiotics

Optibrium™, a developer of software for small molecule drug discovery, and Bugworks Research Inc. (Bugworks), a company focused on discovering biopharmaceuticals for the treatment of critical and serious bacterial infections, today announced the signing of a two-year agreement to license Optibrium’s StarDrop™ software. The agreement will see deployment of StarDrop and five of its plug-in modules enabling Bugworks’ scientists at their research site in India to quickly understand structure-activity relationships, identify potential liabilities and design new compounds with the highest chance of success. Read the press release here...

Next event

We will be exhibiting and presenting at 254th American Chemical Society National Meeting & Exposition, Washington, DC, USA, from 20th – 24th August 2017 More events...

Most recent publication

Peter Hunt, Matthew Segall, Noel O’Boyle*, Roger Sayle* Practical applications of Matched Series Analysis: SAR transfer, binding mode suggestion, and data point validation.*NextMove Software. Future Med. Chem More publications...

Most recent presentation

Layla Hosseini-Gerami presented "Combining quantum and QSAR methods for prediction of acid dissociation constants" at ACS Spring 2017 National Meeting and Exposition, April 2017. More presentations...

Latest Forums

Read more >

Popular Downloads

Read more >